These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38034017)

  • 41. Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency-induced bone mass loss by modulating TRAF6-mediated signaling.
    Hu B; Sun X; Yang Y; Ying Z; Meng J; Zhou C; Jiang G; Li S; Wu F; Zhao X; Zhu H; Wu H; Cai X; Shi Z; Yan S
    FASEB J; 2019 Feb; 33(2):2574-2586. PubMed ID: 30285579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity.
    Huang JM; Wang CZ; Lu SY; Wang Z; Yan ZQ
    Drug Des Devel Ther; 2021; 15():4811-4825. PubMed ID: 34876805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production.
    Lee SY; Lee KS; Yi SH; Kook SH; Lee JC
    PLoS One; 2013; 8(12):e80873. PubMed ID: 24324641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melatonin Inhibits Osteoclastogenesis and Bone Loss in Ovariectomized Mice by Regulating PRMT1-Mediated Signaling.
    Choi JH; Jang AR; Park MJ; Kim DI; Park JH
    Endocrinology; 2021 Jun; 162(6):. PubMed ID: 33713122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways.
    Park GD; Cheon YH; Eun SY; Lee CH; Lee MS; Kim JY; Cho HJ
    Molecules; 2021 May; 26(9):. PubMed ID: 34062884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roburic acid attenuates osteoclastogenesis and bone resorption by targeting RANKL-induced intracellular signaling pathways.
    Wang G; Chen K; Ma C; Wang C; Chen D; He J; Liu Y; Jiang T; Yuan J; Chen L; He W; Xu J
    J Cell Physiol; 2022 Mar; 237(3):1790-1803. PubMed ID: 34796915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
    Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
    Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis.
    Kim M; Kim HS; Kim JH; Kim EY; Lee B; Lee SY; Jun JY; Kim MB; Sohn Y; Jung HS
    BMC Complement Med Ther; 2020 Feb; 20(1):35. PubMed ID: 32024503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.
    He L; Lee J; Jang JH; Lee SH; Nan MH; Oh BC; Lee SG; Kim HH; Soung NK; Ahn JS; Kim BY
    Bone; 2012 Jun; 50(6):1207-13. PubMed ID: 22484180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
    Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
    PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of KIF11 ameliorates osteoclastogenesis via regulating mTORC1-mediated NF-κB signaling.
    Miao J; Yao H; Liu J; Huang Z; Shi C; Lu X; Jiang J; Ren R; Wang C; Pan Y; Wang T; Jin H
    Biochem Pharmacol; 2023 Nov; 217():115817. PubMed ID: 37757917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis
    Yang J; Tang R; Yi J; Chen Y; Li X; Yu T; Fei J
    FASEB J; 2019 Jun; 33(6):7261-7273. PubMed ID: 30857415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prussian Blue Nanozyme Normalizes Microenvironment to Delay Osteoporosis.
    Ye C; Zhang W; Zhao Y; Zhang K; Hou W; Chen M; Lu J; Wu J; He R; Gao W; Zheng Y; Cai X
    Adv Healthc Mater; 2022 Oct; 11(19):e2200787. PubMed ID: 35851764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
    Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longan fruit increase bone mineral density in zebrafish and ovariectomized rat by suppressing RANKL-induced osteoclast differentiation.
    Son Y; Lee EM; Lee DY; Lee JH; Oh S
    Phytomedicine; 2019 Jun; 59():152910. PubMed ID: 30978650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Curculigoside attenuates oxidative stress and osteoclastogenesis via modulating Nrf2/NF-κB signaling pathway in RAW264.7 cells.
    Liu M; Liu S; Zhang Q; Fang Y; Yu Y; Zhu L; Liu Y; Gong W; Zhao L; Qin L; Zhang Q
    J Ethnopharmacol; 2021 Jul; 275():114129. PubMed ID: 33878416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
    Song J; Jing Z; Hu W; Yu J; Cui X
    Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proanthocyanidins inhibit osteoclast formation and function by inhibiting the NF-κB and JNK signaling pathways during osteoporosis treatment.
    Zhu W; Yin Z; Zhang Q; Guo S; Shen Y; Liu T; Liu B; Wan L; Li S; Chen X; Ouyang Z; Peng D
    Biochem Biophys Res Commun; 2019 Jan; 509(1):294-300. PubMed ID: 30583865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Morin attenuates osteoclast formation and function by suppressing the NF-κB, MAPK and calcium signalling pathways.
    Shi Y; Ye L; Shen S; Qian T; Pan Y; Jiang Y; Lin J; Liu C; Wu Y; Wang X; Xu J; Jin H
    Phytother Res; 2021 Oct; 35(10):5694-5707. PubMed ID: 34423505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways.
    Hsiao HB; Lin H; Wu JB; Lin WC
    Osteoporos Int; 2013 May; 24(5):1663-76. PubMed ID: 23143538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.